Patent · US Active

Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitors

US7947694B2 · kind B2 · utility

1Cited by

1References

16Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Eddy Jean Edgard Freyne · Rumst, BE
Jean Fernand Armand Lacrampe · Le Mesnil-Esnard, FR
Timothy Pietro Suren Perera · Felton, GB
Peter Ten Holte · Beerse, BE
Yannick Aime Eddy Ligny · Sotteville-lès-Rouen, FR
Delphine Yvonne Raymonde Lardeau · Issy-les-Moulineaux, FR
Tom Lavrijssen · Vosselaar, BE

Key dates

Filing date	Jan 9, 2006
Grant date	May 24, 2011
Priority date	—
Expiry date	Aug 31, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention comprises the novel compounds of formula (I)wherein R1, R2, R3, R4, R5, R6, X1 and X2 have defined meanings, having cell cycle kinase inhibiting enzymatic activity, their preparation, compositions containing them and their use as a medicine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.